Cargando…
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022
Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of th...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789715/ https://www.ncbi.nlm.nih.gov/pubmed/35018605 http://dx.doi.org/10.1007/s12928-021-00829-9 |
| _version_ | 1784639833524666368 |
|---|---|
| author | Ozaki, Yukio Hara, Hironori Onuma, Yoshinobu Katagiri, Yuki Amano, Tetsuya Kobayashi, Yoshio Muramatsu, Takashi Ishii, Hideki Kozuma, Ken Tanaka, Nobuhiro Matsuo, Hitoshi Uemura, Shiro Kadota, Kazushige Hikichi, Yutaka Tsujita, Kenichi Ako, Junya Nakagawa, Yoshihisa Morino, Yoshihiro Hamanaka, Ichiro Shiode, Nobuo Shite, Junya Honye, Junko Matsubara, Tetsuo Kawai, Kazuya Igarashi, Yasumi Okamura, Atsunori Ogawa, Takayuki Shibata, Yoshisato Tsuji, Takafumi Yajima, Junji Iwabuchi, Kaoru Komatsu, Nobuo Sugano, Teruyasu Yamaki, Masaru Yamada, Shinichiro Hirase, Hiroaki Miyashita, Yuusuke Yoshimachi, Fuminobu Kobayashi, Masakazu Aoki, Jiro Oda, Hirotaka Katahira, Yoshiaki Ueda, Kinzo Nishino, Masami Nakao, Koichi Michishita, Ichiro Ueno, Takafumi Inohara, Taku Kohsaka, Shun Ismail, Tevfik F. Serruys, Patrick W. Nakamura, Masato Yokoi, Hiroyoshi Ikari, Yuji |
| author_facet | Ozaki, Yukio Hara, Hironori Onuma, Yoshinobu Katagiri, Yuki Amano, Tetsuya Kobayashi, Yoshio Muramatsu, Takashi Ishii, Hideki Kozuma, Ken Tanaka, Nobuhiro Matsuo, Hitoshi Uemura, Shiro Kadota, Kazushige Hikichi, Yutaka Tsujita, Kenichi Ako, Junya Nakagawa, Yoshihisa Morino, Yoshihiro Hamanaka, Ichiro Shiode, Nobuo Shite, Junya Honye, Junko Matsubara, Tetsuo Kawai, Kazuya Igarashi, Yasumi Okamura, Atsunori Ogawa, Takayuki Shibata, Yoshisato Tsuji, Takafumi Yajima, Junji Iwabuchi, Kaoru Komatsu, Nobuo Sugano, Teruyasu Yamaki, Masaru Yamada, Shinichiro Hirase, Hiroaki Miyashita, Yuusuke Yoshimachi, Fuminobu Kobayashi, Masakazu Aoki, Jiro Oda, Hirotaka Katahira, Yoshiaki Ueda, Kinzo Nishino, Masami Nakao, Koichi Michishita, Ichiro Ueno, Takafumi Inohara, Taku Kohsaka, Shun Ismail, Tevfik F. Serruys, Patrick W. Nakamura, Masato Yokoi, Hiroyoshi Ikari, Yuji |
| author_sort | Ozaki, Yukio |
| collection | PubMed |
| description | Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version. |
| format | Online Article Text |
| id | pubmed-8789715 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87897152022-02-02 CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 Ozaki, Yukio Hara, Hironori Onuma, Yoshinobu Katagiri, Yuki Amano, Tetsuya Kobayashi, Yoshio Muramatsu, Takashi Ishii, Hideki Kozuma, Ken Tanaka, Nobuhiro Matsuo, Hitoshi Uemura, Shiro Kadota, Kazushige Hikichi, Yutaka Tsujita, Kenichi Ako, Junya Nakagawa, Yoshihisa Morino, Yoshihiro Hamanaka, Ichiro Shiode, Nobuo Shite, Junya Honye, Junko Matsubara, Tetsuo Kawai, Kazuya Igarashi, Yasumi Okamura, Atsunori Ogawa, Takayuki Shibata, Yoshisato Tsuji, Takafumi Yajima, Junji Iwabuchi, Kaoru Komatsu, Nobuo Sugano, Teruyasu Yamaki, Masaru Yamada, Shinichiro Hirase, Hiroaki Miyashita, Yuusuke Yoshimachi, Fuminobu Kobayashi, Masakazu Aoki, Jiro Oda, Hirotaka Katahira, Yoshiaki Ueda, Kinzo Nishino, Masami Nakao, Koichi Michishita, Ichiro Ueno, Takafumi Inohara, Taku Kohsaka, Shun Ismail, Tevfik F. Serruys, Patrick W. Nakamura, Masato Yokoi, Hiroyoshi Ikari, Yuji Cardiovasc Interv Ther Expert Consensus Document Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version. Springer Singapore 2022-01-12 2022 /pmc/articles/PMC8789715/ /pubmed/35018605 http://dx.doi.org/10.1007/s12928-021-00829-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Expert Consensus Document Ozaki, Yukio Hara, Hironori Onuma, Yoshinobu Katagiri, Yuki Amano, Tetsuya Kobayashi, Yoshio Muramatsu, Takashi Ishii, Hideki Kozuma, Ken Tanaka, Nobuhiro Matsuo, Hitoshi Uemura, Shiro Kadota, Kazushige Hikichi, Yutaka Tsujita, Kenichi Ako, Junya Nakagawa, Yoshihisa Morino, Yoshihiro Hamanaka, Ichiro Shiode, Nobuo Shite, Junya Honye, Junko Matsubara, Tetsuo Kawai, Kazuya Igarashi, Yasumi Okamura, Atsunori Ogawa, Takayuki Shibata, Yoshisato Tsuji, Takafumi Yajima, Junji Iwabuchi, Kaoru Komatsu, Nobuo Sugano, Teruyasu Yamaki, Masaru Yamada, Shinichiro Hirase, Hiroaki Miyashita, Yuusuke Yoshimachi, Fuminobu Kobayashi, Masakazu Aoki, Jiro Oda, Hirotaka Katahira, Yoshiaki Ueda, Kinzo Nishino, Masami Nakao, Koichi Michishita, Ichiro Ueno, Takafumi Inohara, Taku Kohsaka, Shun Ismail, Tevfik F. Serruys, Patrick W. Nakamura, Masato Yokoi, Hiroyoshi Ikari, Yuji CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 |
| title | CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 |
| title_full | CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 |
| title_fullStr | CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 |
| title_full_unstemmed | CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 |
| title_short | CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 |
| title_sort | cvit expert consensus document on primary percutaneous coronary intervention (pci) for acute myocardial infarction (ami) update 2022 |
| topic | Expert Consensus Document |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789715/ https://www.ncbi.nlm.nih.gov/pubmed/35018605 http://dx.doi.org/10.1007/s12928-021-00829-9 |
| work_keys_str_mv | AT ozakiyukio cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT harahironori cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT onumayoshinobu cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT katagiriyuki cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT amanotetsuya cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT kobayashiyoshio cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT muramatsutakashi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT ishiihideki cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT kozumaken cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT tanakanobuhiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT matsuohitoshi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT uemurashiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT kadotakazushige cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT hikichiyutaka cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT tsujitakenichi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT akojunya cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT nakagawayoshihisa cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT morinoyoshihiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT hamanakaichiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT shiodenobuo cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT shitejunya cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT honyejunko cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT matsubaratetsuo cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT kawaikazuya cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT igarashiyasumi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT okamuraatsunori cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT ogawatakayuki cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT shibatayoshisato cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT tsujitakafumi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT yajimajunji cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT iwabuchikaoru cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT komatsunobuo cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT suganoteruyasu cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT yamakimasaru cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT yamadashinichiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT hirasehiroaki cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT miyashitayuusuke cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT yoshimachifuminobu cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT kobayashimasakazu cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT aokijiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT odahirotaka cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT katahirayoshiaki cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT uedakinzo cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT nishinomasami cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT nakaokoichi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT michishitaichiro cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT uenotakafumi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT inoharataku cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT kohsakashun cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT ismailtevfikf cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT serruyspatrickw cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT nakamuramasato cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT yokoihiroyoshi cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT ikariyuji cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 AT cvitexpertconsensusdocumentonprimarypercutaneouscoronaryinterventionpciforacutemyocardialinfarctionamiupdate2022 |